The recent epidemic of acquired immunodeficiency syndrome has made it crucially important to elucidate the metabolic factors that influence T lymphocyte senescence in humans, and to determine how they are altered in pathologic states. These are the long-term objectives of the present grant application. With the previous support of the research grant, this laboratory has studied in detail an """"""""experiment of nature"""""""", adenosine deaminase deficiency, which also produces selective attrition of T lymphocytes. The results of our investigations suggest that normal T cells have a tightly regulated """"""""programmed cell death"""""""" mechanisms, which links DNA integrity to adenine nucleotide metabolism via the action of the chromatin-bound enzyme poly(ADP-ribose) synthetase. In adenosine deaminase deficient children, the accumulation of dATP in T cells triggers the suicide pathway and leads to cells lysis. Exposure of lymphocytes to reactive oxygen species causes lymphocyte dysfunction via the same mechanism. The renewal application aims to analyze the individual metabolic components of the programmed cell death pathway in T lymphocytes, emphasizing the factors that control DNA strand break formation and repair, the regulation of poly(ADP-ribose) synthetase, and the coordination of NAD+ and ATP synthesis and catabolism. Additional experiments will determine how these parameters are changed by exposure of the cells to deoxyadenosine and toxic oxygen species, and most importantly, by infection with human immunodeficiency virus (HIV). Related techniques will be used to analyze lymphocytes from patients with acquired immunodeficiency syndrome, as well as cells from a recently discovered group of patients with high titers of autoantibodies to poly(ADP-ribose) synthetase. Based upon the results, strategies will be pursued to modify pharmacologically the programmed cell death pathway in vitro, and eventually in vivo.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM023200-13
Application #
3271540
Study Section
(SSS)
Project Start
1976-06-30
Project End
1992-06-30
Budget Start
1988-07-01
Budget End
1989-06-30
Support Year
13
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
San Diego
State
CA
Country
United States
Zip Code
92037
Wu, Christina C N; Hayashi, Tomoko; Takabayashi, Kenji et al. (2007) Immunotherapeutic activity of a conjugate of a Toll-like receptor 7 ligand. Proc Natl Acad Sci U S A 104:3990-5
Barchechath, Sylvie D; Tawatao, Rommel I; Corr, Maripat et al. (2005) Inhibitors of apoptosis in lymphocytes: synthesis and biological evaluation of compounds related to pifithrin-alpha. J Med Chem 48:6409-22
Barchechath, Sylvie D; Tawatao, Rommel I; Corr, Maripat et al. (2005) Quinolinium salt as a potent inhibitor of lymphocyte apoptosis. Bioorg Med Chem Lett 15:1785-8
Lu, Desheng; Zhao, Yandong; Tawatao, Rommel et al. (2004) Activation of the Wnt signaling pathway in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 101:3118-23
Wu, Christina C N; Lee, Jongdae; Raz, Eyal et al. (2004) Necessity of oligonucleotide aggregation for toll-like receptor 9 activation. J Biol Chem 279:33071-8
Wu, Christina C N; Castro, Januario E; Motta, Marina et al. (2003) Selection of oligonucleotide aptamers with enhanced uptake and activation of human leukemia B cells. Hum Gene Ther 14:849-60
Pioletti, Dominique P; Leoni, Lorenzo; Genini, Davide et al. (2002) Gene expression analysis of osteoblastic cells contacted by orthopedic implant particles. J Biomed Mater Res 61:408-20
Rhee, Chae-Seo; Sen, Malini; Lu, Desheng et al. (2002) Wnt and frizzled receptors as potential targets for immunotherapy in head and neck squamous cell carcinomas. Oncogene 21:6598-605
Hua, X H; Genini, D; Gussio, R et al. (2001) Biochemical genetic analysis of indanocine resistance in human leukemia. Cancer Res 61:7248-54
Leoni, L M; Hamel, E; Genini, D et al. (2000) Indanocine, a microtubule-binding indanone and a selective inducer of apoptosis in multidrug-resistant cancer cells. J Natl Cancer Inst 92:217-24

Showing the most recent 10 out of 70 publications